Plain-English translation of NCT06615752 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 1/2 — A combined trial that checks safety and dosing while also starting to look at whether the treatment works.
This study is testing whether adding green tea and quercetin—natural plant-based supplements—to docetaxel chemotherapy can improve treatment outcomes for men with metastatic castration-resistant prostate cancer (advanced prostate cancer that no longer responds to hormone therapy). Half of the participants will receive the real supplements along with chemotherapy, and the other half will receive look-alike placebo capsules with the same chemotherapy, so researchers can see if the medication makes a real difference.
Once prostate cancer stops responding to hormone treatments, options become limited. Researchers believe that these natural plant compounds may help boost the cancer-fighting power of chemotherapy and potentially reduce side effects, but this combination hasn't been carefully studied in patients yet.
You likely qualify if…
You likely don't qualify if…
You will be randomly assigned to receive either green tea and quercetin capsules or placebo capsules, both given alongside your regular docetaxel chemotherapy and prednisone treatment. You'll take the capsules as directed and continue with your chemotherapy schedule as planned by your doctor. Throughout the study, you'll have regular visits for blood tests, check-ins, and monitoring to track how well the treatment is working and watch for any side effects.
AI-generated summary from trial data · Jul 3, 2026 · Not medical advice
United States